About Biostride
Biostride is a Healthcare company based in Redwood City (United States) founded in 1990 by Henry Tom and Laura Colin, and was acquired by Medix Biochemica in June 2020. Antibodies, antigens, and enzyme conjugates are developed and manufactured. Its focus areas include Traditional Pharmaceuticals.
Company details
Biostride was established in 1990 in Redwood City, United States, by co-founders Henry Tom and Laura Colin. Operations focus on the biotechnology sector, where antibodies, antigens, and enzyme conjugates are developed and manufactured for research and diagnostic applications. The company maintains its headquarters in the United States, supporting global distribution of these biological reagents through standard industry channels.
- Headquarters Redwood City, United States
- Founders Henry Tom, Laura Colin
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website biostrideinc.com
- Social LinkedIn
- Acquired by Medix Biochemica (Jun 2020)
- Investors
- Acquired byMedix Biochemica
(Jun 2020)
Investors in Biostride
Biostride has secured backing from 1 investor. Prominent investors backing the company include Medix Biochemica.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Develops and markets rapid diagnostic tests and bioreagents | 1985 | medixbiochemica.com | Espoo, Finland |
Investor details for Biostride
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Biostride
2 people are tracked at Biostride (2 in leadership).
| Name | Role | Group |
|---|---|---|
Henry Tom | Co-Founder | Leadership |
Laura Colin | Co-Founder | Leadership |
Complete people profiles for Biostride
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Biostride
2 dated milestones of Biostride across 30 years, from founding to its latest funding, stage changes and deals.
- Founded Biostride is founded.
- Exit Acquired by Medix Biochemica.
Top companies in Traditional Health & Nutrition
3 companies that operate in the same segment as Biostride (Traditional Health & Nutrition) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Manufacturer of generics formulations | 2002 | Bridgewater, New Jersey, United States | USD 3.02 B | 8,300 | ||
Biosimilar therapeutics are developed for oncology and autoimmune diseases. | 2010 | Redwood City, California, United States | USD 143.62 M | USD 42.17 M | 228 | |
Ophthalmic pharmaceuticals and instruments are developed for eye care. | 1853 | Bridgewater, New Jersey, United States | USD 5.1 B | 13,500 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Biostride
Biostride was founded in 1990.
Biostride is headquartered in Redwood City, United States. It is registered at Redwood City, California, United States.
Biostride was established in 1990 in Redwood City, United States, by co-founders Henry Tom and Laura Colin. Operations focus on the biotechnology sector, where antibodies, antigens, and enzyme conjugates are developed and manufactured for research and diagnostic applications. The company maintains its headquarters in the United States, supporting global distribution of these biological reagents through standard industry channels.
Biostride has 1 investor. Key investors include Medix Biochemica.
Yes. Biostride was acquired by Medix Biochemica in June 2020.